Understanding & Control of Material Process Variance in Generic Drug Manufacturer (Q233375): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in de: translated_label) |
(Created claim: summary (P836): Verständnis & Kontrolle der Materialprozessvarianz im Generikahersteller, translated_summary) |
||||||||||||||
| Property / summary | |||||||||||||||
Verständnis & Kontrolle der Materialprozessvarianz im Generikahersteller (German) | |||||||||||||||
| Property / summary: Verständnis & Kontrolle der Materialprozessvarianz im Generikahersteller (German) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: Verständnis & Kontrolle der Materialprozessvarianz im Generikahersteller (German) / qualifier | |||||||||||||||
point in time: 25 November 2021
| |||||||||||||||
Revision as of 21:25, 25 November 2021
Project Q233375 in Ireland
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Understanding & Control of Material Process Variance in Generic Drug Manufacturer |
Project Q233375 in Ireland |
Statements
102,773.69 Euro
0 references
205,547.38 Euro
0 references
50.0 percent
0 references
1 March 2015
0 references
20 August 2017
0 references
University of Limerick
0 references
Understanding & Control of Material Process Variance in Generic Drug Manufacturer (English)
0 references
Comprendre & Contrôle de la variation du processus matériel chez le fabricant de médicaments génériques (French)
25 November 2021
0 references
Verständnis & Kontrolle der Materialprozessvarianz im Generikahersteller (German)
25 November 2021
0 references
Identifiers
305
0 references